These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9721817)

  • 1. Mycophenolate mofetil and cough.
    Elli A; Aroldi A; Montagnino G; Tarantino A; Ponticelli C
    Transplantation; 1998 Aug; 66(3):409. PubMed ID: 9721817
    [No Abstract]   [Full Text] [Related]  

  • 2. Omission of azathioprine and mycophenolate mofetil in immunosuppressive regimen in kidney transplantation.
    Taheri M; Pourmand G; Mehrsai AR; Mansoori D
    Transplant Proc; 2003 Nov; 35(7):2752-3. PubMed ID: 14612105
    [No Abstract]   [Full Text] [Related]  

  • 3. How to handle mycophenolate mofetil in combination with tacrolimus?
    Braun F; Canelo R; Schütz E; Shipkora M; Lorf T; Hanack U; Niedmann D; Armstrong VW; Oellerich M; Ringe B
    Transplant Proc; 1998 Dec; 30(8):4094-5. PubMed ID: 9865309
    [No Abstract]   [Full Text] [Related]  

  • 4. Co-administration of tacrolimus and mycophenolate mofetil in cadaveric renal transplant recipients.
    Vanrenterghem Y; Squifflet JP; Forsythe J; Heeman U; Bäckman L; Taube D; Morales JM; Ekberg H; van Hooff J; Zanker B; Dietl KH; Talbot D; Hauser I; Tydén G; Claesson K; Mühlbacher F
    Transplant Proc; 1998 Jun; 30(4):1290-1. PubMed ID: 9636523
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of mycophenolate mofetil on progression of chronic allograft nephropathy.
    Yeung S; Lee W; Tong KL; Tsang WK; Chan HW
    Transplant Proc; 2003 Feb; 35(1):176-8. PubMed ID: 12591355
    [No Abstract]   [Full Text] [Related]  

  • 6. [Mycophenolate mofetil: a new approach by immunosuppressive treatment].
    Thervet E
    Pathol Biol (Paris); 2001 Feb; 49(1):9-11. PubMed ID: 11265229
    [No Abstract]   [Full Text] [Related]  

  • 7. [Mycophenolate mofetil and cough in pediatric patients].
    Fijo J; Martín Govantes J
    Nefrologia; 2000; 20(3):297-8. PubMed ID: 10917009
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of mycophenolate mofetil on hematocrit after renal transplantation.
    Chenhsu RY; Wu YM; Min DI; Zimmerman MB
    Ann Pharmacother; 2002 Sep; 36(9):1479-80. PubMed ID: 12196073
    [No Abstract]   [Full Text] [Related]  

  • 9. Relapse of atypical haemolytic uraemic syndrome after kidney transplantation: role of ATG and failure of mycophenolate mofetil as rescue therapy.
    Davin JC; Gruppen M; Bouts AH; Groothoff JW; van Amstel SP; Surachno J; ten Berge IJ; Weening JJ
    Nephrol Dial Transplant; 1999 Apr; 14(4):984-7. PubMed ID: 10328487
    [No Abstract]   [Full Text] [Related]  

  • 10. Conversion to mycophenolate mofetil for chronic progressive deterioration of renal allograft function: first clinical experiences in 44 patients.
    Fritsche L; Sperschneider H; Budde K; Giessing M; Morgera S; Schröder K; Stein G; Neumayer HH
    Transplant Proc; 1998 Jun; 30(4):1190-1. PubMed ID: 9636481
    [No Abstract]   [Full Text] [Related]  

  • 11. Mycophenolate mofetil as maintenance immunosuppression in pediatric renal transplantation.
    Ettenger R; Cohen A; Nast C; Moulton L; Marik J; Gales B
    Transplant Proc; 1997; 29(1-2):340-1. PubMed ID: 9123030
    [No Abstract]   [Full Text] [Related]  

  • 12. Tolerability of mycophenolate mofetil in organ transplant recipients.
    Schweizer RT; Meisterling LD
    Transplant Proc; 2001 May; 33(3):2309. PubMed ID: 11377540
    [No Abstract]   [Full Text] [Related]  

  • 13. Mycophenolate mofetil rescue therapy in liver transplant recipients: an extended follow-up.
    Gavlik A; Demirbas A; Tsaroucha A; Webb MG; Nery JR; Khan MF; Karatzas T; Khan RT; Zucker K; Viciana AL; Miller JA; Tzakis AG
    Transplant Proc; 1997 Nov; 29(7):2971-2. PubMed ID: 9365633
    [No Abstract]   [Full Text] [Related]  

  • 14. Mycophenolate mofetil (Cellcept) in renal transplantation: the European experience. The European Mycophenolate Mofetil Co-operative Study Group.
    Carl S; Wiesel M
    Transplant Proc; 1997 Nov; 29(7):2932-5. PubMed ID: 9365619
    [No Abstract]   [Full Text] [Related]  

  • 15. Safety of the allopurinol-mycophenolate mofetil combination in the treatment of hyperuricemia of kidney transplant recipients.
    Navascués RA; Gómez E; Rodriguez M; Laures AS; Baltar J; Grande JA
    Nephron; 2002 May; 91(1):173-4. PubMed ID: 12021539
    [No Abstract]   [Full Text] [Related]  

  • 16. Mycophenolate mofetil.
    Becker BN
    Transplant Proc; 1999 Nov; 31(7):2777-8. PubMed ID: 10578287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triple therapy with mycophenolate mofetil versus azathioprine.
    Muñiz ML; Amenabar J; Gómez-Ullate P; Urbizu J; Lampreabe I
    Transplant Proc; 1999; 31(1-2):1144-6. PubMed ID: 10083512
    [No Abstract]   [Full Text] [Related]  

  • 18. Tacrolimus and mycophenolate mofetil in cadaveric renal transplant recipients. The European Multicentre Tacrolimus/MMF Study Group.
    Forsythe J
    Transplant Proc; 1999 Nov; 31(7A):69S-71S. PubMed ID: 10576049
    [No Abstract]   [Full Text] [Related]  

  • 19. Mycophenolate mofetil in pregnancy after renal transplantation: a case of major fetal malformations.
    Le Ray C; Coulomb A; Elefant E; Frydman R; Audibert F
    Obstet Gynecol; 2004 May; 103(5 Pt 2):1091-4. PubMed ID: 15121619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycophenolate mofetil, along with ATG and cyclosporine, significantly lowers the incidence of acute rejection episodes in renal transplant recipients.
    Puig JM; Lloveras J; Fernández-Crespo P; Mir M; Iñigo V; Manresa JM; Masramón J
    Transplant Proc; 1999 Sep; 31(6):2259-60. PubMed ID: 10500567
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.